AstraZeneca’s COVID vaccine sales reached $4B last year, but don’t expect that much in 2022news2022-02-10T15:10:16+00:00February 10th, 2022|Fierce Pharma|
Hologic goes big with Mary J. Blige at the Super Bowlnews2022-02-10T14:53:34+00:00February 10th, 2022|Fierce Pharma|
Elanco completes sale of a pair of plants to CDMO TriRx in Kansas and UKnews2022-02-10T14:39:08+00:00February 10th, 2022|Fierce Pharma|
AstraZeneca R&D chiefs talk roxadustat trial, Ultomiris threats and Imfinzi wingman treme’s futurenews2022-02-10T14:17:48+00:00February 10th, 2022|Fierce Pharma|
Teva CEO says company could pay up to $3.6B to put opioid litigation to bed: reportnews2022-02-10T13:48:14+00:00February 10th, 2022|Fierce Pharma|
Skyepharma inks deal to build largest microbiome facility in Francenews2022-02-10T13:42:55+00:00February 10th, 2022|Fierce Pharma|
American Lung Association campaign, backed by pharma, tackles lack of diversity in lung cancer trialsnews2022-02-10T13:42:29+00:00February 10th, 2022|Fierce Pharma|
Seagen, Genmab run ‘CeMe’ cervical cancer campaign amid Tivdak launchnews2022-02-10T11:38:21+00:00February 10th, 2022|Fierce Pharma|
AbbVie’s Qulipta gains ground with docs for migraine prevention, as pharma looks to pressure Biohaven’s Nurtecnews2022-02-10T09:45:22+00:00February 10th, 2022|Fierce Pharma|
House Republicans, advocacy groups urge HHS to abandon measure that would restrict coverage of Biogen’s Aduhelmnews2022-02-09T20:58:52+00:00February 9th, 2022|Fierce Pharma|
